Stock Comparison

ARGX vs RVMD

argenx NV ADR and Revolution Medicines Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

RVMD

Revolution Medicines Inc

Healthcare

Valuation

Market Cap

$55.44B

$38.71B

P/E (TTM)

39.4

—

Forward P/E

34.0

—

Price/Sales

11.7

9,035.1

Price/Book

7.5

25.8

EV/EBITDA

33.9

-9.7

Dividend Yield

—

Profitability

Net Margin

31.40%

0.00%

Operating Margin

30.00%

0.00%

Return on Equity

20.20%

-76.70%

Return on Assets

8.86%

-37.50%

Growth (YoY)

Revenue Growth

62.60%

-95.20%

Earnings Growth

114.00%

0.00%

Price & Risk

Beta

-0.0

1.4

52-Week High

$934.62

$184.39

52-Week Low

$510.06

$34.00

Analyst Target

$1,041.14

$188.57

Compare ARGX and RVMD your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.